Skip to main content
. 2020 Jul 28;7:366. doi: 10.3389/fmed.2020.00366

Figure 3.

Figure 3

Course of cancer antigen 125 (CA-125) levels in relation to applied therapies; course of tumor markers over time. Arrows indicate application of nivolumab therapy.